{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:26:27Z","timestamp":1773246387552,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1023\/a:1009646705467","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T22:47:08Z","timestamp":1040597228000},"page":"161-169","source":"Crossref","is-referenced-by-count":10,"title":["Elevated cytokeratin-19 expression associated with apoptotic resistance and malignant progression of human cervical carcinoma"],"prefix":"10.1007","volume":"3","author":[{"given":"C-C.","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T-S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-T","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R-S.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-W.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L-C.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"176436_CR1","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/1097-0142(19890815)64:4<962::AID-CNCR2820640432>3.0.CO;2-B","volume":"64","author":"P Chou","year":"1989","unstructured":"Chou P, Chen V. Mass screening for cervical cancer in Taiwan. Cancer 1989; 64: 962\u2013968.","journal-title":"Cancer"},{"key":"176436_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634340","volume":"256","author":"HT Ng","year":"1995","unstructured":"Ng HT, Yuan CC, Kan YY, Ho ESC, Yen MS, Chao KC. An evaluation of chemotherapy in patients with cancer of cervix and lymph node metastases. Arch General Obstet 1995; 256: 1\u20134.","journal-title":"Arch General Obstet"},{"key":"176436_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0090-8258(90)90153-C","volume":"36","author":"M Brodman","year":"1990","unstructured":"Brodman M, Friedman F Jr, Dotting P, Janus C, Plaxe S, Cohen C. A comparative study of computerized tomography, magnetic resonance imaging, and staging for the detection of early cervix cancer. Gynecol Oncol 1990; 36: 409\u2013412.","journal-title":"Gynecol Oncol"},{"key":"176436_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0002-9378(79)90889-5","volume":"134","author":"LD Lagasse","year":"1979","unstructured":"Lagasse LD, Ballon SC, Berman ML, Watring WG. Pretreatment lymphangiography and operative evaluation in carcinoma of the cervix. Am J Obstet Gynecol 1979; 134: 219\u2013224.","journal-title":"Am J Obstet Gynecol"},{"key":"176436_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/1097-0142(197808)42:2<581::AID-CNCR2820420226>3.0.CO;2-G","volume":"42","author":"EM Rutanen","year":"1978","unstructured":"Rutanen EM, Lindgren J, Sipponen P, Stenman UH, Saksela E, Seppala M. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors. Cancer 1978; 42: 581\u2013590.","journal-title":"Cancer"},{"key":"176436_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/1097-0142(197902)43:2<585::AID-CNCR2820430227>3.0.CO;2-0","volume":"43","author":"H Kato","year":"1979","unstructured":"Kato H, Miyauchi F, Morioka H, Fujino T, Torigoe T. Tumor antigen of human cervical squamous cell carcinoma. Correlation of circulating levels with disease progress. Cancer 1979; 43: 585\u2013590.","journal-title":"Cancer"},{"key":"176436_CR7","first-page":"603","volume":"61","author":"PN Bamford","year":"1983","unstructured":"Bamford PN, Ormerod MG, Sloane JP, Warburton MJ. An immunohistochemical study of the distribution of epithelial antigens in the uterine cervix. Obstet Gynecol 1983; 61: 603\u2013608.","journal-title":"Obstet Gynecol"},{"key":"176436_CR8","first-page":"7","volume":"50","author":"CP Lam","year":"1992","unstructured":"Lam CP, Yuan CC, Jeng FS, Tsai LC, Yeh SH, Ng HT. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers. Chin Med J (Taipei) 1992; 50: 7\u201313.","journal-title":"Chin Med J (Taipei)"},{"key":"176436_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/bjc.1992.42","volume":"65","author":"CC Yuan","year":"1992","unstructured":"Yuan CC, Tsai LC, Hsu SC, et al. Production and characterization of a monoclonal antibody (Cx-99) against cervical carcinoma. Br J Cancer 1992; 65: 201\u2013207.","journal-title":"Br J Cancer"},{"key":"176436_CR10","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-70230-3","volume-title":"Intermediate Filaments: A Review","author":"P. Traub","year":"1985","unstructured":"Traub P. Intermediate Filaments: A Review. Berlin, Germany: Springer, 1985."},{"key":"176436_CR11","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1016\/0006-2952(89)90527-3","volume":"38","author":"RA Roberts","year":"1989","unstructured":"Roberts RA, Cress AE, Dalton WS. Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line. Biochem Pharmacol 1989; 38: 4283\u20134290.","journal-title":"Biochem Pharmacol"},{"key":"176436_CR12","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1073\/pnas.91.12.5311","volume":"91","author":"PA Bauman","year":"1994","unstructured":"Bauman PA, Dalton WS, Anderson JM, Cress AE. Expression of cytokeratin confers multiple drug resistance. Proc Natl Acad Sci USA 1994; 91: 5311\u20135314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176436_CR13","first-page":"97","volume":"2","author":"JM Anderson","year":"1996","unstructured":"Anderson JM, Heindl LM, Bauman PA, Ludi CW, Dalton WS, Cress AE. Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents. Clin Cancer Res 1996; 2: 97\u2013105.","journal-title":"Clin Cancer Res"},{"key":"176436_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/A:1026448027870","volume":"2","author":"CC Yuan","year":"1997","unstructured":"Yuan CC, Huang HC, Tsai LC, Ng HT, Huang TS. Cytokeratin-19 associated with apoptosis and chemosensitivity in human cervical cancer cells. Apoptosis 1997; 2: 101\u2013105.","journal-title":"Apoptosis"},{"key":"176436_CR15","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/(SICI)1097-0142(19970501)79:9<1647::AID-CNCR3>3.0.CO;2-9","volume":"79","author":"K Yamamoto","year":"1997","unstructured":"Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T, Suzuki T. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 1997; 79: 1647\u20131655.","journal-title":"Cancer"},{"key":"176436_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0009-9120(93)90129-T","volume":"26","author":"P Stieber","year":"1993","unstructured":"Stieber P, Bodenmuller H, Banauch D, et al. Cytokeratin 19 fragments: A new marker for non-small-cell lung cancer. Clin Biochem 1993; 26: 301\u2013304.","journal-title":"Clin Biochem"},{"key":"176436_CR17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1378\/chest.108.1.163","volume":"108","author":"B Wieskopf","year":"1995","unstructured":"Wieskopf B, Demangeat C, Purohit A, et al. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. Chest 1995; 108: 163\u2013169.","journal-title":"Chest"},{"key":"176436_CR18","first-page":"609","volume":"63","author":"M Szturmowicz","year":"1995","unstructured":"Szturmowicz M, Sakowicz A, Wiatr E, et al. Evaluation of the value of determining levels of cytokeratin-19 fragments for diagnosis of lung cancer. Pneumonol Alergol Pol1995; 63: 609\u2013614.","journal-title":"Pneumonol Alergol Pol"},{"key":"176436_CR19","first-page":"615","volume":"63","author":"B Cynowska","year":"1995","unstructured":"Cynowska B, Slominski JM, Wyrwinski J. Level of cytokeratin-19 in serum of patients with non small cell lung cancer. Pneumonol Alergol Pol 1995; 63: 615\u2013620.","journal-title":"Pneumonol Alergol Pol"},{"key":"176436_CR20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/172460089601100306","volume":"11","author":"M Szturmowicz","year":"1996","unstructured":"Szturmowicz M, Sakowicz A, Rudzinski P, et al. The clinical value of Cyfra 21-1 estimation for lung cancer patients. Int J Biol Markers 1996; 11: 172\u2013177.","journal-title":"Int J Biol Markers"},{"key":"176436_CR21","first-page":"287","volume":"9","author":"LC Tsai","year":"1985","unstructured":"Tsai LC, Wang FM, Pan LC, Perng AC, Han SH. Immunological characteristics of monoclonal antibodies against human carcinoembryonic antigen (CEA). Proc Natl Sci Counc B ROC 1985; 9: 287\u2013297.","journal-title":"Proc Natl Sci Counc B ROC"},{"key":"176436_CR22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1042\/bj0890114","volume":"39","author":"FC Greenwood","year":"1963","unstructured":"Greenwood FC, Hunter WM, Glover JS. The preparation of 125I-labeled human growth hormone of high specific radioactivity. Biochem J 1963; 39: 114\u2013123.","journal-title":"Biochem J"},{"key":"176436_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0304-3835(96)04464-3","volume":"110","author":"TS Huang","year":"1996","unstructured":"Huang TS, Shu CH, Shih YL, et al. Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide. Cancer Lett 1996; 110: 77\u201385.","journal-title":"Cancer Lett"},{"key":"176436_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF01321105","volume":"1","author":"TS Huang","year":"1996","unstructured":"Huang TS, Yang WK, Whang-Peng J. GL331-induced disruption of cyclin B1\/CDC 2 complex and inhibition of CDC 2 kinase activity. Apoptosis 1996; 1: 213\u2013217.","journal-title":"Apoptosis"},{"key":"176436_CR25","first-page":"625","volume":"13","author":"TS Huang","year":"1996","unstructured":"Huang TS, Kuo ML, Shew JY, Chou YW, Yang WK. Distinct p53-mediated G1\/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents. Oncogene 1996; 13: 625\u2013632.","journal-title":"Oncogene"},{"key":"176436_CR26","first-page":"332","volume":"5","author":"LC Tsai","year":"1988","unstructured":"Tsai LC, Cheng HM, Yeh SH, Yuan CC, Tsao D, Han SH. Localization of human colorectal antibody to carcinoembryonic antigen. Diagn Clin Immunol 1988; 5: 332\u2013337.","journal-title":"Diagn Clin Immunol"},{"key":"176436_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF01321020","volume":"1","author":"CH Shu","year":"1996","unstructured":"Shu CH, Yang WK, Huang TS. Increased cyclin B1\/CDC 2 kinase activity and phosphorylation of Bcl-2 associated with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis 1996; 1: 141\u2013146.","journal-title":"Apoptosis"},{"key":"176436_CR28","first-page":"2974","volume":"57","author":"TS Huang","year":"1997","unstructured":"Huang TS, Shu CH, Yang WK, Whang-Peng J. Activation of CDC 25 phosphatase and CDC 2 kinase involved in GL331-induced apoptosis. Cancer Res 1997; 57: 2974\u20132978.","journal-title":"Cancer Res"},{"key":"176436_CR29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1749-6632.1985.tb50418.x","volume":"455","author":"RA Quinlan","year":"1985","unstructured":"Quinlan RA, Schiller DL, Hatzfeld M, et al. Patterns of expression and organization of cytokeratin intermediate filaments. Ann NY Acad Sci 1985; 455: 282\u2013306.","journal-title":"Ann NY Acad Sci"},{"key":"176436_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000292728","volume":"34","author":"SA. Farghaly","year":"1992","unstructured":"Farghaly SA. Tumor markers in gynecologic cancer. Gynecol Obstet Invest 1992; 34: 65\u201372.","journal-title":"Gynecol Obstet Invest"},{"key":"176436_CR31","first-page":"1841","volume":"13","author":"M Ferdeghini","year":"1993","unstructured":"Ferdeghini M, Gadducci A, Annicchiarico C, et al. Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix. Anticancer Res 1993; 13: 1841\u20131844.","journal-title":"Anticancer Res"},{"key":"176436_CR32","first-page":"944","volume":"74","author":"RW Holloway","year":"1989","unstructured":"Holloway RW, To A, Moradi M, Boots L, Watson N, Shingleton HM. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radio-immuoassay. Obstet Gynecol 1989; 74: 944\u2013949.","journal-title":"Obstet Gynecol"},{"key":"176436_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00006254-199002000-00003","volume":"45","author":"TW. Hontag","year":"1990","unstructured":"Hontag TW. Tumor markers in gynecologic oncology. Obstet Gynecol Surv 1990; 45: 94\u2013105.","journal-title":"Obstet Gynecol Surv"},{"key":"176436_CR34","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(79)92386-9","volume":"2","author":"T Wahlstrom","year":"1979","unstructured":"Wahlstrom T, Lingren J, Korhonen M, Seppapa M. Distribution between endo-cervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens. Lancet 1979; 2: 1159\u20131161.","journal-title":"Lancet"},{"key":"176436_CR35","first-page":"1034","volume":"91","author":"RE Fray","year":"1984","unstructured":"Fray RE, Husain OA, To AC, et al. The value of immunohistochemical markers in the diagnosis of cervical neoplasia. Br J Obstet Gynecol 1984; 91: 1034\u20131041.","journal-title":"Br J Obstet Gynecol"},{"issue":"Suppl1","key":"176436_CR36","first-page":"S18","volume":"18","author":"WH Kruger","year":"1996","unstructured":"Kruger WH, Stockschlader M, Hennings S, et al. Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transplant 1996; 18 (Suppl 1): S18\u201320.","journal-title":"Bone Marrow Transplant"},{"key":"176436_CR37","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/BF01209032","volume":"122","author":"WH Kruger","year":"1996","unstructured":"Kruger WH, Krzizanowski C, Holweg M, et al. Reverse transcriptase\/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 1996; 122: 679\u2013686.","journal-title":"J Cancer Res Clin Oncol"},{"key":"176436_CR38","first-page":"57","volume":"25","author":"M Hildebrandt","year":"1997","unstructured":"Hildebrandt M, Mapara MY, Korner IJ, Bargou RC, Moldenhauer G, Dorken B. Reverse transcriptasepolymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: A sensitive method for monitoring purging efficiency. Exp Hematol 1997; 25: 57\u201365.","journal-title":"Exp Hematol"},{"key":"176436_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0968-0004(94)90170-8","volume":"19","author":"SJ Martin","year":"1994","unstructured":"Martin SJ, Green DR, Cotter TG. Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem Sci 1994; 19: 26\u201330.","journal-title":"Trends Biochem Sci"},{"key":"176436_CR40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1126\/science.6186022","volume":"219","author":"LW Knapp","year":"1983","unstructured":"Knapp LW, O'Guin WM, Sawyer RH. Drug-induced alterations of cytokeratin organization in cultured epithelial cells. Science 1983; 219: 501\u2013503.","journal-title":"Science"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1009646705467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1009646705467\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1009646705467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T15:38:04Z","timestamp":1747582684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1009646705467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["176436"],"URL":"https:\/\/doi.org\/10.1023\/a:1009646705467","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}